FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1522701000168101: glucose 200 g / 2.053 L injection, 1.053 L chamber (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4518721000168110 glucose 200 g / 2.053 L injection, 1.053 L chamber (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4518731000168113 glucose 200 g/2.053 L injection, 1.053 L chamber en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
glucose 200 g/2.053 L injection, 1.053 L chamber Is a glucose true Inferred relationship Some
glucose 200 g/2.053 L injection, 1.053 L chamber Is a medicinal product unit of use true Inferred relationship Some
glucose 200 g/2.053 L injection, 1.053 L chamber has manufactured dose form injection true Inferred relationship Some
glucose 200 g/2.053 L injection, 1.053 L chamber has unit of use chamber true Inferred relationship Some 1209624686
glucose 200 g/2.053 L injection, 1.053 L chamber has intended active ingredient glucose true Inferred relationship Some 1048045911
glucose 200 g/2.053 L injection, 1.053 L chamber has Australian BoSS glucose true Inferred relationship Some 1048045911
Inbound Relationships Type Active Source Characteristic Refinability Group
Kabiven G19% Glucose 200 g/2.053 L injection, 1.053 L chamber Is a True glucose 200 g/2.053 L injection, 1.053 L chamber Inferred relationship Some
glucose 200 g/2.053 L injection [1.053 L chamber] (&) alanine 9.6 g/2.053 L + arginine 6.8 g/2.053 L + aspartic acid 2 g/2.053 L + glutamic acid 3.4 g/2.053 L + glycine 4.7 g/2.053 L + histidine 4.1 g/2.053 L + isoleucine 3.4 g/2.053 L + leucine 4.7 g/2.053 L + lysine hydrochloride 6.8 g/2.053 L + methionine 3.4 g/2.053 L + phenylalanine 4.7 g/2.053 L + proline 4.1 g/2.053 L + serine 2.7 g/2.053 L + threonine 3.4 g/2.053 L + tryptophan 1.1 g/2.053 L + tyrosine 140 mg/2.053 L + valine 4.4 g/2.053 L + calcium chloride dihydrate 590 mg/2.053 L + sodium glycerophosphate 3 g/2.053 L + magnesium sulfate heptahydrate 2 g/2.053 L + potassium chloride 3.6 g (potassium 48 mmol)/2.053 L + sodium acetate trihydrate 4.9 g/2.053 L injection [600 mL chamber] (&) soya oil 80 g/2.053 L injection [400 mL chamber], 4 x 2.053 L multi-chamber bags has MPUU True glucose 200 g/2.053 L injection, 1.053 L chamber Inferred relationship Some 1021049768
glucose 200 g/2.053 L injection [1.053 L chamber] (&) alanine 9.6 g/2.053 L + arginine 6.8 g/2.053 L + aspartic acid 2 g/2.053 L + glutamic acid 3.4 g/2.053 L + glycine 4.7 g/2.053 L + histidine 4.1 g/2.053 L + isoleucine 3.4 g/2.053 L + leucine 4.7 g/2.053 L + lysine hydrochloride 6.8 g/2.053 L + methionine 3.4 g/2.053 L + phenylalanine 4.7 g/2.053 L + proline 4.1 g/2.053 L + serine 2.7 g/2.053 L + threonine 3.4 g/2.053 L + tryptophan 1.1 g/2.053 L + tyrosine 140 mg/2.053 L + valine 4.4 g/2.053 L + calcium chloride dihydrate 590 mg/2.053 L + sodium glycerophosphate 3 g/2.053 L + magnesium sulfate heptahydrate 2 g/2.053 L + potassium chloride 3.6 g (potassium 48 mmol)/2.053 L + sodium acetate trihydrate 4.9 g/2.053 L injection [600 mL chamber] (&) soya oil 80 g/2.053 L injection [400 mL chamber], 2.053 L multi-chamber bag has MPUU True glucose 200 g/2.053 L injection, 1.053 L chamber Inferred relationship Some 578990447

Reference Sets

Medicinal product unit of use reference set

Back to Start